- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 6, 2026 | 12.05M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 8.64M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 5.91M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2023 | 5.24M sh |
| Capex | FY 2025 · Dec 31, 2025 | $12.09M |
| Capex | FY 2025 · Dec 31, 2024 | $25.14M |
| Capex | FY 2025 · Dec 31, 2023 | $28.66M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$30.44M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$15.13M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | −$19.77M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $95M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $183.24M |
| Cash And Equivalents | FY 2025 · Dec 31, 2023 | $210.78M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$44.5M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$67.32M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $48.14M |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $68.09M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $122.57M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $139.94M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $499.16M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $675.09M |
| Current Assets | FY 2025 · Dec 31, 2025 | $137.12M |
| Current Assets | FY 2025 · Dec 31, 2024 | $231.22M |
| Total Assets | FY 2025 · Dec 31, 2025 | $454.67M |
| Total Assets | FY 2025 · Dec 31, 2024 | $607.78M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$12.39 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$22.70 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | −$19.17 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$8.57 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$22.70 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | −$19.17 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $44.44M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $79.76M |
| Sga Expense restated | FY 2025 · Dec 31, 2023 | $91.17M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $54.71M |
| Rd Expense restated | FY 2025 · Dec 31, 2024 | $79.78M |
| Rd Expense restated | FY 2025 · Dec 31, 2023 | $103.86M |
| Net Income | FY 2025 · Dec 31, 2025 | −$67.23M |
| Net Income | FY 2025 · Dec 31, 2024 | −$134.27M |
| Net Income | FY 2025 · Dec 31, 2023 | −$100.44M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$78.7M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$183.2M |
| Operating Income | FY 2025 · Dec 31, 2023 | −$111.38M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $69.39M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2024 | $77.4M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2023 | $116.06M |
| Revenue | FY 2025 · Dec 31, 2025 | $243.74M |
| Revenue | FY 2025 · Dec 31, 2024 | $312.47M |
| Revenue | FY 2025 · Dec 31, 2023 | $401.98M |